Neuro-ophthalmologic manifestations of systemic disease: Rheumatologic/Inflammatory

Ophthalmology Clinics of North America

Volumn 17, Issue 3, 2004, Pages 389-396

  Golnik, Karl C ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CHLOROQUINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

BEHCET DISEASE; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CROHN DISEASE; ENTERITIS; EYE DISEASE; HUMAN; INFLAMMATION; KERATOCONJUNCTIVITIS; NEUROLOGIC DISEASE; NEUROOPHTHALMOLOGY; OPHTHALMOPLEGIA; ORBIT PSEUDOTUMOR; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SARCOIDOSIS; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS;

EYE DISEASES; HUMANS; INFLAMMATION; NERVOUS SYSTEM DISEASES; RHEUMATIC DISEASES;

EID: 4444288607     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ohc.2004.05.004     Document Type: Review

References (90)

1. Rybicki B.A., Major M., Popovich J., Maliarik M.J., Iannuzzi M.C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 145:1997;234-241
2. Thomas P.D., Hunninghake G.W. Current concepts of the pathogenesis of sarcoidosis. Am Rev Resp Dis. 135:1987;747-760
3. Gullapalli D., Phillips L.H. Neurologic manifestations of sarcoidosis. Neurol Clin. 20:2002;59-83
4. Jabs D., Johns C. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 102:1986;297-301
5. Chapelon C., Ziza J.M., Piette J.C.H., et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine. 69:1990;261-276
6. Stern B.J., Krumholz A., Johns C., et al. Sarcoidosis and its neurological manifestations. Arch Neurol. 42:1985;909-917
7. Constantino T., Digre K., Zimmerman P. Neuro-ophthalmic complications of sarcoidosis. Semin Neurol. 20:2000;123-137
8. Graham E., Ellis C., Sanders M., et al. Optic neuropathy in sarcoidosis. J Neurol Neurosurg Psychiatry. 6:1986;47-52
9. Scott T.F. Neurosarcoidosis: progress and clinical aspects. Neurology. 43:1993;8-12
10. Poole C. Argyll Robertson pupils due to neurosarcoidosis: evidence for site of lesion. BMJ. 289:1984;356
11. Pelton R.W., Lee A.G., Orengo-Nania S.D., et al. Bilateral optic disc edema caused by sarcoidosis mimicking pseudotumor cerebri. Am J Ophthalmol. 12:1999;229-230
12. Katz J.M., Bruno M.K., Winterkorn J.S., et al. The pathogenesis and treatment of optic disc swelling in neurosarcoidosis. Arch Neurol. 60:2003;426-430
13. Kosmorsky G.S., Prayson R. Primary optic pathway sarcoidosis in a 38-year-old white man. J Neuroophthalmol. 16:1996;188-190
14. Christoforidis G.A., Spickler E.M., Recio M.V., et al. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol. 20:1999;655-659
15. Frohman L.P., Grigorian R., Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuroophthalmol. 21:2001;132-137
16. Power W., Neves R., Rodriguez A., et al. The value of combined serum angiotensin-converting enzyme and gallium scan in diagnosing ocular sarcoidosis. Ophthalmology. 102:1995;2007-2111
17. Kosmorsky G.S., Meisler D.M., Rice T.W., et al. Chest computed tomography and mediastinoscopy in the diagnosis of sarcoidosis-associated uveitis. Am J Ophthalmol. 126:1998;132-134
18. Agbogu B.N., Stern B.J., Sewell C., et al. Therapeutic considerations in refractory neurosarcoidosis. Arch Neurol. 52:1995;875-879
19. Doty J.D., Mazur J.E., Judson M.A. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest. 124:2003;2023-2026
20. Gelwan M., Kellen R., Burde R., et al. Sarcoidosis of the anterior visual pathways: successes and failures. J Neurol Neurosurg Psychiatry. 51:1988;1473-1480
21. Yuen S.J.A., Rubin P.A.D. Idiopathic orbital inflammation. Arch Ophthalmol. 121:2003;491-499
22. Fujii H., Fujisada H., Kondo T., et al. Orbital pseudotumor: histopathological classification and treatment. Ophthalmologica. 190:1985;230-242
23. Mombaerts I., Schlingemann R.O., Goldschmeding R., et al. Idiopathic granulomatous orbital inflammation. Ophthalmology. 103:1996;2135-2141
24. Moon W.J., Na D.G., Ryoo J.W., et al. Orbital lymphoma and subacute or chronic inflammatory pseudotumor: differentiation with two-phase helical computed tomography. J Comput Assist Tomogr. 27:2003;510-516
25. Yuen S.J., Rubin P.A. Idiopathic orbital inflammation: ocular mechanisms and clinicopathology. Ophthalmol Clin N Am. 15:2002;121-126
26. Mombaerts I., Schlingemann R.O., Goldschmeding R., et al. Are systemic corticosteroids useful in the management of orbital pseudotumors? Ophthalmology. 103:1996;521-528
27. Mannor G.E., Rose G.E., Moseley I.F., et al. Outcome of orbital myositis: clinical features associated with recurrence. Ophthalmology. 104:1997;409-414
28. Paris G.L., Waltuch G., Egbert P.R. Treatment of refractory orbital pseudotumors with pulsed chemotherapy. Ophthal Plast Reconstr Surg. 6:1990;96-101
29. Shah S.S., Lowder C.Y., Schmitt M.A., et al. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology. 99:1992;1419-1423
30. Lanciano R., Fowble B., Sergott R., et al. The results of radiotherapy for orbital pseudotumor. Int J Radiat Oncol Biol Phys. 18:1990;407-411
31. Rootman J., McCarthy M., White V., et al. Idiopathic sclerosing inflammation of the orbit: a distinct clinicopathologic entity. Ophthalmology. 101:1994;570-584
32. Cruz A.A.V., Akaishi P.M.S., Chahud F., et al. Sclerosing inflammation in the orbit and in the pterygopalatine and infratemporal fossae. Ophthal Plast Reconstr Surg. 19:2003;201-206
33. Greenstein A.J., Janowitz H.D., Sachar D.B. The extra-intestinal complications of Crohn's disease and ulcerative colitis. Medicine. 55:1976;401-412
34. Lossos A., River Y., Eliamkin A., et al. Neurologic aspects of inflammatory bowel disease. Neurology. 45:1995;416-423
35. Kraus J.A., Nahser H.C., Berlit P. Lymphocytic encephalomyeloneuritis as a complication of ulcerative colitis. J Neurol Sci. 141:1996;117-119
36. Kao A., Dlugos D., Hunter J.V., et al. Anticoagulation therapy in cerebral sinovenous thrombosis and ulcerative colitis in children. J Child Neurol. 17:2002;479-482
37. Ghanchi F.D., Rembacken B.J. Inflammatory bowel disease and the eye. Surv Ophthalmol. 48:2003;663-676
38. Hutnik C.M.L., Nicolle D.A., Canny C.L.B. Papillitis: a rare initial presentation of Crohn's disease. Can J Ophthalmol. 31:1996;373-376
39. Knox D.L., Schachat A.P., Mustonen E. Primary, secondary, and coincidental ocular complications of Crohn's disease. Ophthalmology. 91:1984;163-173
40. Keyser B.J., Haas A.N. Retinal vascular disease in ulcerative colitis. Am J Ophthalmol. 118:1994;395-396
41. Truelove S.C., Witts L.J. Cortisone in ulcerative colitis. Final report on a controlled trial. BMJ. 2:1955;1041-1048
42. Nilsson A., Danielson A., Lofberg R., et al. Olsalazine versus sulfasalazine for relapse in ulcerative colitis: a multicenter study. Am J Gastroenterol. 90:1995;381-387
43. Feagan B.G., Rochon J., Fedorak R.N., et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group investigators. N Engl J Med. 332:1995;292-297
44. Leavitt R.Y., Fauci A.S., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum. 33:1990;1101-1107
45. Nadeau S.E. Neurologic manifestations of systemic vasculitis. Neurol Clin. 20:2002;123-149
46. Fauci A.S., Haynes B.F., Katz P., et al. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med. 98:1983;76-85
47. Drachman D.A. Neurologic complications of Wegener's granulomatosis. Arch Neurol. 8:1963;145-155
48. Newman N.J., Slamovits T.L., Friedland S., et al. Neuro-ophthalmic manifestations of meningocerebral inflammation from the limited form of Wegener's granulomatosis. Am J Ophthalmol. 120:1995;613-621
49. Iida T., Spaide R.F., Kantor J. Retinal and choroidal arterial occlusion in Wegener's granulomatosis. Am J Ophthalmol. 133:2002;151-152
50. Stavrou P., Deutsch J., Rene C., et al. Ocular manifestations of classical and limited Wegener's granulomatosis. Q J Med. 86:1993;719-725
51. Haynes B.F., Fisherman M.L., Fauci A.S., et al. Ocular manifestations of Wegener's granulomatosis: 15 years' experience and a review of the literature. Am J Med. 63:1977;131-141
52. Provenzale J.M., Allen N.B. Wegener granulomatosis: CT and MR findings. AJNR Am J Neuroradiol. 17:1996;785-792
53. Tishler S., Williamson T., Mirra S.S., et al. Wegener granulomatosis with meningeal involvement. AJNR Am J Neuroradiol. 14:1993;1248-1252
54. Stegeman C.A., Tervaert J.W.C., de Jong P.E., et al. Trimethoprim- sulfamethoxazole (co-trimoxazole) for the prevention of relapses in Wegener's granulomatosis. N Engl J Med. 335:1996;16-20
55. Guillevin L., Jarrousse B., Lok C., et al. Long-term follow-up after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange. A prospective randomized trial of 71 patients. J Rheumatol. 18:1991;567-574
56. Guillevin L., Lhote F., Gherardi R. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment. Neurol Clin. 15:1997;865-886
57. Kirkali P., Topaloglu R., Kansu T., et al. Third nerve palsy and internuclear ophthalmoplegia in periarteritis nodosa. J Pediatr Ophthalmol Strabismus. 28:1991;45-46
58. Jeanette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 37:1994;187-192
59. Sehgal M., Swanson J.W., DeRemee R.A., et al. Neurologic manifestations of Churg-Strauss syndrome. Mayo Clin Proc. 70:1995;337-341
60. Kattah J.C., Chrousos G.A., Katz P.A., et al. Anterior ischemic optic neuropathy in Churg-Strauss syndrome. Neurology. 44:1994;2200-2202
61. Takanashi T., Uchida S., Machiko A., et al. Orbital inflammatory pseudotumor and ischemic vasculitis in Churg-Strauss syndrome. Ophthalmology. 108:2001;1129-1133
62. Vitali C., Genovisi-Ebert F., Romani A., et al. Ophthalmological and neuro-ophthalmological involvement in Churg-Strauss syndrome: a case report. Graefes Arch Clin Exp Ophthalmol. 234:1996;404-408
63. Kone-Paut I., Chabrol B., Riss J.M., et al. Neurologic onset of Behcet's disease: a diagnostic enigma in childhood. J Child Neurol. 12:1997;237-241
64. Devlin T., Gray L., Allen N.B., et al. Neuro-Behcet's disease: factors hampering proper diagnosis. Neurology. 45:1995;1754-1757
65. Ashjazadeh N., Borhani Haghighi A., Samangooie S., et al. Neuro-Behcet's disease: a masquerader of multiple sclerosis. A prospective study of neurologic manifestations of Behcet's disease in 96 Iranian patients. Exp Mol Pathol. 74:2003;17-22
66. Watanabe T., Sato T., Uchiumi T., et al. Neuropsychiatric manifestations in patients with systemic lupus erythematosis: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody. Lupus. 5:1996;178-183
67. Seaman D.E., Londino A.V., Kowh C.K., et al. Antiphospholipid antibodies in pediatric systemic lupus erythematosis. Pediatrics. 96:1995;1040-1045
68. Golstein M., Meyer O., Bourgeois P., et al. Neurologic manifestations of systemic lupus erythematosis: role of antiphospholipid antibodies. Clin Exp Rheumatol. 11:1993;373-379
69. McLean B.N. Neurological involvement in systemic lupus erythematosis. Curr Opin Neurol. 11:1998;247-251
70. West S.G. Lupus and the nervous system. Curr Opin Rheumatol. 8:1996;408-414
71. Keane J.R. Eye movement abnormalities in systemic lupus erythematosis. Arch Neurol. 52:1995;1145-1149
72. Stavrou P., Murray P.I., Batta K., et al. Acute ocular ischemia and orbital inflammation associated with systemic lupus erythematosis. Br J Ophthalmol. 86:2002;474-475
73. Galindo-Rodriguez G., Avina-Zubieta A., Pizarro S., et al. Cyclophosphamide pulse therapy in optic neuritis due to systemic lupus erythematosis: an open trial. Am J Med. 106:1999;65-69
74. Krieg T., Meurer M. Systemic scleroderma: clinical and pathophysiologic aspects. J Am Acad Dermatol. 18:1988;457-481
75. Nadeau S.E. Neurologic manifestations of connective tissue disease. Neurol Clin. 20:2002;151-177
76. Averbuch-Heller L., Steiner I., Abramsky O. Neurologic manifestations of progressive systemic sclerosis. Arch Neurol. 49:1992;1292-1295
77. Chung M.H., Sum J., Morrell M.J., et al. Intracerebral involvement in scleroderma en coup de sabre: report of a case with neuropathologic findings. Ann Neurol. 37:1995;679-681
78. Campbell W.W., Bahandas F.J. Restrictive ophthalmopathy associated with linear scleroderma. J Neuroophthalmol. 15:1995;95-97
79. Rosler D.H., Conway M.D., Anaya J.M., et al. Ischemic optic neuropathy and high levels of anticardiolipin antibody in primary Sjogren's syndrome. Lupus. 4:1995;155-157
80. Lafitte C., Amoura Z., Cacoub P., et al. Neurological complications of primary Sjogren's syndrome. J Neurol. 248:2001;577-584
81. Tajima Y., Mito Y., Owada Y., et al. Neurological manifestations of primary Sjogren's syndrome in Japanese patients. Intern Med. 36:1997;690-693
82. Rapoport P., Merle H., Smadja D. Ischemic choroidopathy in primary Sjogren's syndrome. Acta Ophthalmol Scand. 76:1998;627-628
83. Bachmeyer C., Zuber M., Dupont S., et al. Adie syndrome as the initial sign of primary Sjogren syndrome. Am J Ophthalmol. 123:1997;691-692
84. Chang D.J., Paget S.A. Neurologic complications of rheumatoid arthritis. Rheum Dis Clin North Am. 4:1993;955-973
85. Harper S.L., Foster C.S. The ocular manifestations of rheumatoid disease. Int Ophthalmol Clin. 38:1998;1-19
86. Bland J.H. Rheumatoid arthritis of the cervical spine. J Rheumatol. 1:1974;319-342
87. Beck D.O., Corbett J.J. Seizures due to central nervous system rheumatoid meningovasculitis. Neurology. 33:1983;1058-1061
88. Ramos M., Mandybur T.I. Cerebral vasculitis in rheumatoid arthritis. Arch Neurol. 32:1975;271-275
89. Davidson R.C., Horn J.R., Herndon J.H., et al. Brain-stem compression in rheumatoid arthritis. JAMA. 238:1977;2633-2634
90. Cooper C., Kirwan J.R., McGill N.W., et al. Brown's syndrome: an unusual ocular complication of rheumatoid arthritis. Ann Rheum Dis. 49:1990;188-189